Individualised nutrition not only helps patients consume more protein and calories, but also improves clinical treatment outcomes and reduces mortality rate, according to a Swiss study of more than 2,000 patients.
With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.
A combination of regulatory hurdles and growing consumer demand for more effective products means companies are looking for new ways to innovate with encapsulation technologies and delivery systems, say experts speaking to NutraIngredients.
The Clinical Nutrition market is set to witness annual growth of over 8.1% to 2025, spurred in part by nutritional supplements as healthcare providers increasingly focus on prevention, according to new research by Global Market Insights (GMI).
Nutrition solutions for critically ill patients should not ignore the potential of modulating gut bacteria for health, say researchers who suggest current enteral feeding solutions do not support gut defences and the microbiome.
Medical nutrition terminology is not consistently defined - with frequent inconsistencies between definitions and regulations relating to specific terms and practices, warn researchers who argue that standardised terminology is needed.
Bacteria in our guts may be impacting human health and disease by telling host genes what to do, say researchers who have uncovered a new mechanism by which our microbiome communicates with and controls the DNA of our own cells.